Neil Stahl
2013
In 2013, Neil Stahl earned a total compensation of $14.4M as Executive Vice President, Research & Development at Regeneron Pharmaceuticals, a 20% increase compared to previous year.
Compensation breakdown
| Bonus | $386,208 |
|---|---|
| Option Awards | $13,474,403 |
| Salary | $476,800 |
| Other | $17,235 |
| Total | $14,354,646 |
Stahl received $13.5M in option awards, accounting for 94% of the total pay in 2013.
Stahl also received $386.2K in bonus, $476.8K in salary and $17.2K in other compensation.
Rankings
In 2013, Neil Stahl's compensation ranked 195th out of 12,286 executives tracked by ExecPay. In other words, Stahl earned more than 98.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 195 out of 12,286 | 98th |
Division Manufacturing | 60 out of 4,614 | 99th |
Major group Chemicals And Allied Products | 16 out of 1,466 | 99th |
Industry group Drugs | 11 out of 1,160 | 99th |
Industry Pharmaceutical Preparations | 9 out of 890 | 99th |
Source: SEC filing on April 26, 2016.
Stahl's colleagues
We found five more compensation records of executives who worked with Neil Stahl at Regeneron Pharmaceuticals in 2013.
2013
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2013
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2013
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
2013
Robert Terifay
Regeneron Pharmaceuticals
Executive Vice President, Commercial
2013
Murray Goldberg
Regeneron Pharmaceuticals